ArticleBioengineering (Basel, Switzerland)2023

Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites.

Thomas Später et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.